We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00772798
Recruitment Status : Unknown
Verified October 2008 by Herlev Hospital.
Recruitment status was:  Recruiting
First Posted : October 15, 2008
Last Update Posted : October 15, 2008
Sponsor:
Collaborator:
Odense University Hospital
Information provided by:
Herlev Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : June 2009
  Estimated Study Completion Date : June 2009